LG Chem expands pharma push with $566m deal for U.S. drugmaker
nikkei.com
business
2022-10-21 14:41:37

LG Chem is ramping up research in the growing biopharmaceutical field. (Photo courtesy of LG Chem) KOTARO HOSOKAWA, Nikkei staff writerOctober 21, 2022 23:41 JST | South KoreaSEOUL -- South Korea's LG Chem will buy Aveo Pharmaceuticals in a deal valued at $566 million, tapping the oncology-focused American drugmaker to expand its foothold in the growing biopharmaceutical market.LG Chem will pay $15 a share for all of Aveo's outstanding stock, according to an announcement this week. The transaction is expected to close in early 2023, once it is greenlighted by shareholders.
